[試題] 106-2 廖永豐 分子神經病理學 期末考

看板NTU-Exam作者 (lynch)時間5年前 (2018/06/14 20:45), 編輯推噓0(000)
留言0則, 0人參與, 最新討論串1/1
課程名稱︰分子神經病理學 課程性質︰選修 課程教師︰廖永豐/陳志成 開課學院:生命科學院 開課系所︰生命科學系 考試日期(年月日)︰2018/06/14 考試時限(分鐘):180 試題 : Please answer the following questions concisely. 廖永豐部分 Please write your answers to questions 1-4 in one sheet of exam paper.(YL and LHY) 1.(i) Please describe how you can prove that Abeta-elicited neurotoxicity results from its oligomeric form, but not its fibrillar form. (4 pts.) (ii) Accumulating evidence has strongly suggested that both Abeta- and Tau-elicited toxicity can contribute to the pathogenesis of Alzheimer's disease (AD). Please describe one experimental conclusion supporting the notion that the crosstalk between Abeta- and Tau-elicited signaling can instigate AD. (6 pts.) 2.(i) The pathogenesis of Parkinson's disease (PD) has been linked to the increased level of alpha-synuclein in neurons. Please propose one therapeutic strategy that targets the alpha-synuclein-mediated neurodegeneration in PD. (6 pts.) (ii) Mitochondrial dysfunction seems to play a central role in PD pathogenesis. Please describe one potential disease-modifying therapy for PD that targets mitochondrial dysfunction and how this potential therapy works. (4 pts.) 3. Hu et al. (J. Exp. Med., 215:927-940, 2018) showed that BACE1 deletion in the adult mouse can reduce Abeta deposition and improve cognitve functions In light of recently reported failure in the randomized trial of Verubecestat (a BACE1 inhibitor) for AD, in which treatments with the BACE1 inhibitor do not reduce cognitive decline in patients with mild-to-moderate AD (N. Engl. J. Med., 378:1691-703, 2018), how would you reconcile the different conclusions between the results from the animal study and human trial? (5 pts.) 4. Please briefly discuss how the genomic lesions selectively impact the nervous system in a cell type-specific manner. (10 pts.) 陳志成部分 Please write your answers to questions 5-7 in the other sheet of exam paper. (CC) 5. Huntington disease is an inheritable neurodegenerative disease. Please describe the genetic component causing the disease (1 pt) and how the gene mutation affects the neurons in terms of loss of function and gain of function (9 pts.). 6. (a) Please describe the hypothesis and establoshed models to assay anxiety-like behaviors in mice. (4 pts.) (b) Please describe the underlying mechanisms that contribute to LPS-induced sickness and depression-like symptoms; and how to distinguish these two symptoms in animal behaviors. (6 pts.) 7. Please describe one of the key experiments that can demonstrate skeletal muscle is involved in sleep regulation. (5 pts.) Exam time: 3h. Format: open-book. -- ※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 140.109.65.208 ※ 文章網址: https://www.ptt.cc/bbs/NTU-Exam/M.1528980354.A.ECD.html
文章代碼(AID): #1R8cE2xD (NTU-Exam)